(Q46558929)

23 December 2017

title

Cellular imaging predictions of clinical drug-induced liver injury (English)

1 reference

23 December 2017

author name string

Jinghai J Xu

1

1 reference

23 December 2017

Peter V Henstock

2

1 reference

23 December 2017

Margaret C Dunn

3

1 reference

23 December 2017

Arthur R Smith

4

1 reference

23 December 2017

Jeffrey R Chabot

5

1 reference

23 December 2017

David de Graaf

6

1 reference

23 December 2017

publication date

3 June 2008

1 reference

23 December 2017

published in

Toxicological Sciences

1 reference

23 December 2017

volume

105

1 reference

23 December 2017

issue

1

1 reference

23 December 2017

page(s)

97-105

1 reference

23 December 2017

Nonsteroidal anti-inflammatory drug-induced hepatotoxicity

cites work

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFN109

Mechanisms of NSAID-induced hepatotoxicity: focus on nimesulide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFN109

Mitochondrial abnormalities--a link to idiosyncratic drug hepatotoxicity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFN109

Identifying Important Risk Factors for Survival in Kidney Graft Failure Patients Using Random Survival Forests

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFN109

Cytochrome P450 3A4-mediated bioactivation of raloxifene: irreversible enzyme inhibition and thiol adduct formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFN109

Human variability in xenobiotic metabolism and pathway-related uncertainty factors for chemical risk assessment: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFN109

21 January 2018

When good drugs go bad.

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFN109

Influence of Matrigel-overlay on constitutive and inducible expression of nine genes encoding drug-metabolizing enzymes in primary human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFN109

Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFN109

P-glycoprotein expression, localization, and function in sandwich-cultured primary rat and human hepatocytes: relevance to the hepatobiliary disposition of a model opioid peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFN109

Tamoxifen cytotoxicity in hepatoblastoma cells stably transfected with human CYP3A4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFN109

Mechanisms of drug-induced liver injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFN109

Idiosyncratic drug hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFN109

Resveratrol, a red wine polyphenol, attenuates ethanol-induced oxidative stress in rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFN109

Role of mitochondria in drug-induced cholestatic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFN109

How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFN109

The use of receiver operating characteristic curves in biomedical informatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFN109

Effects of human pharmaceuticals on cytotoxicity, EROD activity and ROS production in fish hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFN109

Drug-induced hepatotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFN109

Recognizing drug-induced liver injury: current problems, possible solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFN109

A review of the common properties of drugs with idiosyncratic hepatotoxicity and the "multiple determinant hypothesis" for the manifestation of idiosyncratic drug toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFN109

Drug-related hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFN109

High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFN109

Concordance of the toxicity of pharmaceuticals in humans and in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFN109

Gene expression profiling of extracellular matrix as an effector of human hepatocyte phenotype in primary cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFN109

Hepatotoxicity due to mitochondrial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFN109

The FDA and the case of Ketek

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFN109

Why drugs fail--a study on side effects in new chemical entities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFN109

Drug hepatotoxicity from a regulatory perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFN109

Can pharmacogenetics help rescue drugs withdrawn from the market?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFN109

"Let there be bile"--understanding hepatic injury in cholestasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFN109

Reduced mitochondrial coenzyme Q10 levels in HepG2 cells treated with high-dose simvastatin: a possible role in statin-induced hepatotoxicity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFN109

Hepatotoxicity of antibiotics and antifungals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFN109

Idiosyncratic drug reactions: past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFN109

Idiosyncratic toxicity: a convergence of risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFN109

Idiosyncratic liver injury: challenges and approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFN109

Characterisation of some cytotoxic endpoints using rat liver and HepG2 spheroids as in vitro models and their application in hepatotoxicity studies. II. Spheroid cell spreading inhibition as a new cytotoxic marker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFN109

Applications of cytotoxicity assays and pre-lethal mechanistic assays for assessment of human hepatotoxicity potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFN109

NADPH-dependent covalent binding of [3H]paroxetine to human liver microsomes and S-9 fractions: identification of an electrophilic quinone metabolite of paroxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFN109

21 January 2018

Identifiers

DOI

10.1093/TOXSCI/KFN109

1 reference

23 December 2017

1 reference

23 December 2017